RT @FrontImmunol: New Research: Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associate…
702 followers
376 followers
RT @FrontImmunol: New Research: Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associate…
281 followers
RT @FrontImmunol: New Research: Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associate…
32,811 followers
New Research: Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer: Objective Few data are available on the… #immunology htt